Safety, Tolerability and Relative Bioavailability of Pegvisomant in Healthy Subjects

NCT01181973 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioavailability

Interventions

DRUG: pegvisomant
DRUG: pegvisomant
DRUG: pegvisomant
DRUG: pegvisomant

Sponsor

Pfizer